— Proceeds Will Fund Completion of GT-30 Trial of Personalized Therapeutic Cancer Vaccine in Liver Cancer — — Shanghai-based SHC Added to Geneos’ Investor Syndicate — PLYMOUTH MEETING, Pa., Sept. 27, 2023 /PRNewswire/ — Geneos Therapeutics, a clinical stage biotherapeutics company…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.